The JSE gained for the fourth day on Friday, reaching its best level in four years on Covid-19 vaccine and US stimulus optimism, even as new Covid-19 restrictions threatened sentiment. 

This week, the UK became the first country to authorise emergency use of a vaccine developed by Pfizer and BioNTech, marking another step in the battle against the pandemic...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.